In the BioHarmony Drug Report Database

"Preview" Icon

Bismuth subsalicylate

Helidac (bismuth subsalicylate) is a small molecule pharmaceutical. Bismuth subsalicylate was first approved as Helidac on 1996-08-15. It is used to treat bacillary dysentery, diarrhea, dyspepsia, escherichia coli infections, and helicobacter infections amongst others in the USA.

 

Trade Name

 

Helidac
 

Common Name

 

bismuth subsalicylate
 

ChEMBL ID

 

CHEMBL1120
 

Indication

 

bacillary dysentery, diarrhea, dyspepsia, escherichia coli infections, helicobacter infections, nausea, stomach diseases, virus diseases
 

Drug Class

 

Anti-inflammatory agents (salicylic acid derivatives)

Image (chem structure or protein)

Bismuth subsalicylate structure rendering